PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
CEA 17,022 Target Disease Nephrotic Syndrome 14,681 3 0.00 -1.00 0.00 0.51
CEA 17,022 Target Disease Skin Rash 3,684 6 0.00 -1.00 0.00 0.56
CEA 17,022 Target Disease Hypothyroidism 23,397 15 0.00 -1.00 0.00 0.54
CEA 17,022 Target Disease Seizures 66,465 20 0.00 -1.00 0.00 0.52
CEA 17,022 Target Disease Ovarian Cyst 1,959 19 0.00 -0.99 0.01 0.61
CEA 17,022 Target Disease Sarcoidosis 19,176 13 0.00 -1.00 0.00 0.54
CEA 17,022 Target Disease Constipation 15,810 14 0.00 -1.00 0.00 0.55
CEA 17,022 Target Disease Dyskinesia 9,738 1 0.00 -1.00 0.00 0.49
CEA 17,022 Target Disease Cardiac Dysrhythmia 289 1 0.00 -1.00 0.00 0.57
CEA 17,022 Target Disease Acute Promyelocytic Leukemia 4,780 1 0.00 -1.00 0.00 0.51
CEA 17,022 Target Disease Insomnia 12,434 4 0.00 -1.00 0.00 0.52
CEA 17,022 Target Disease Tuberculosis 146,217 54 0.00 -1.00 0.00 0.52
CEA 17,022 Target Disease Chronic Obstructive Pulmonary Disease 27,780 39 0.00 -1.00 0.00 0.57
CEA 17,022 Target Disease Skin Cancer 11,561 5 0.00 -1.00 0.00 0.53
CEA 17,022 Target Disease Dehydration 21,928 3 0.00 -1.00 0.00 0.49
CEA 17,022 Target Disease Aggression 20,035 19 0.00 -1.00 0.00 0.55
CEA 17,022 Target Disease Hyperglycemia 28,168 7 0.00 -1.00 0.00 0.51
CEA 17,022 Target Disease Diarrhea 51,986 67 0.00 -1.00 0.00 0.57
CEA 17,022 Target Disease Inflammatory Bowel Disease 24,375 43 0.00 -1.00 0.00 0.58
CEA 17,022 Target Disease Infectious Diseases 33,605 16 0.00 -1.00 0.00 0.53
CEA 17,022 Target Disease Infection 766,637 215 0.00 -0.99 0.01 0.51
CEA 17,022 Target Disease Kidney Diseases 4,651 1 0.00 -1.00 0.00 0.51
CEA 17,022 Target Disease Glaucoma 41,465 4 0.00 -1.00 0.00 0.48
CEA 17,022 Target Disease Schizophrenia 77,034 11 0.00 -1.00 0.00 0.49
CEA 17,022 Target Disease Bladder Cancer 21,509 60 0.00 -1.00 0.00 0.60
CEA 17,022 Target Disease Lichen Planus 5,287 1 0.00 -1.00 0.00 0.50
CEA 17,022 Target Disease Opiate Dependence 807 5 0.00 -1.00 0.01 0.59
CEA 17,022 Target Disease Mad Cow Disease 222 1 0.00 -1.00 0.00 0.57
CEA 17,022 Target Disease Prostate Cancer 71,064 67 0.00 -1.00 0.00 0.55
CEA 17,022 Target Disease Diabetes Mellitus Type 2 1,311 1 0.00 -1.00 0.00 0.54
CEA 17,022 Target Disease Chronic Lymphocytic Leukemia 11,642 6 0.00 -1.00 0.00 0.53
CEA 17,022 Target Disease Anxiety 113,510 219 0.00 -0.99 0.01 0.58
Alpha (Prolastin)- FDA 13 Drug Disease Leukemia 162,805 1 0.00 -0.96 0.08 0.57
Alpha (Prolastin)- FDA 13 Drug Disease Heart Disease 118,291 1 0.00 -0.96 0.08 0.58
Arcalyst (Rilonacept)- FDA 1 Drug Disease Inflammation 252,734 1 0.00 -0.71 1.00 0.60
CEA 17,022 Target Disease Osteoarthritis 36,287 8 0.00 -1.00 0.00 0.51
CEA 17,022 Target Disease Cancer 1,053,491 6,937 0.05 -0.77 0.41 0.63
CEA 17,022 Target Disease Nausea 42,627 78 0.00 -1.00 0.00 0.58
CEA 17,022 Target Disease Fibromyalgia 6,837 1 0.00 -1.00 0.00 0.50
CEA 17,022 Target Disease Enlarged Prostate 388 1 0.00 -1.00 0.00 0.56
CEA 17,022 Target Disease Acute Pain 4,876 3 0.00 -1.00 0.00 0.53
CEA 17,022 Target Disease Brain Injury 34,874 6 0.00 -1.00 0.00 0.50
CEA 17,022 Target Disease Carcinoma Squamous Cell 47 1 0.00 -0.99 0.02 0.60
CEA 17,022 Target Disease Parkinsonism 13,164 2 0.00 -1.00 0.00 0.50
CEA 17,022 Target Disease Back Pain 30,003 26 0.00 -1.00 0.00 0.55
CEA 17,022 Target Disease Arrhythmia 29,330 14 0.00 -1.00 0.00 0.53
CEA 17,022 Target Disease Conjunctivitis 8,825 1 0.00 -1.00 0.00 0.49
CEA 17,022 Target Disease Fracture 111,575 13 0.00 -1.00 0.00 0.49
CEA 17,022 Target Disease Bone Cancer 798 1 0.00 -1.00 0.00 0.55
CEA 17,022 Target Disease Ovarian Cancer 33,996 223 0.01 -0.99 0.01 0.63
CEA 17,022 Target Disease Tremor 14,317 3 0.00 -1.00 0.00 0.51
CEA 17,022 Target Disease Hepatitis B 57,815 35 0.00 -1.00 0.00 0.54
CEA 17,022 Target Disease Stroke 146,992 1,358 0.03 -0.95 0.08 0.65
CEA 17,022 Target Disease Dyspnea 24,781 31 0.00 -1.00 0.00 0.56
CEA 17,022 Target Disease Hyperbilirubinemia 5,757 5 0.00 -1.00 0.00 0.55
CEA 17,022 Target Disease Sleep Apnea 18,342 1 0.00 -1.00 0.00 0.47
CEA 17,022 Target Disease Postgastrectomy 829 2 0.00 -1.00 0.00 0.56
CEA 17,022 Target Disease Arthritis 128,324 35 0.00 -1.00 0.00 0.51
CEA 17,022 Target Disease Diabetic Nephropathy 12,496 3 0.00 -1.00 0.00 0.51
CEA 17,022 Target Disease Anemia 81,663 58 0.00 -1.00 0.00 0.54
CEA 17,022 Target Disease Benign Prostatic Hyperplasia 10,026 3 0.00 -1.00 0.00 0.52
CEA 17,022 Target Disease Obsessive Compulsive Disorder 8,508 1 0.00 -1.00 0.00 0.49
CEA 17,022 Target Disease Hypotension 42,123 65 0.00 -1.00 0.00 0.57
CEA 17,022 Target Disease Major Depressive Disorder 12,517 3 0.00 -1.00 0.00 0.51
CEA 17,022 Target Disease Joint Pain 4,215 1 0.00 -1.00 0.00 0.51
CEA 17,022 Target Disease Headache 50,687 46 0.00 -1.00 0.00 0.55
CEA 17,022 Target Disease Osteopetrosis 2,017 1 0.00 -1.00 0.00 0.53
CEA 17,022 Target Disease Celiac Disease 8,026 1 0.00 -1.00 0.00 0.49
CEA 17,022 Target Disease Acute Coronary Syndromes 9,133 3 0.00 -1.00 0.00 0.52
CEA 17,022 Target Disease Sentinel Lymph Node Biopsy 3,064 3 0.00 -1.00 0.00 0.55
CEA 17,022 Target Disease Hypocalcemia 6,174 1 0.00 -1.00 0.00 0.50
CEA 17,022 Target Disease Epilepsy 71,172 6 0.00 -1.00 0.00 0.48
CEA 17,022 Target Disease Allergic Rhinitis 12,280 1 0.00 -1.00 0.00 0.48
CEA 17,022 Target Disease Cryptococcosis 3,853 2 0.00 -1.00 0.00 0.53
CEA 17,022 Target Disease Organ Transplantation 11,384 1 0.00 -1.00 0.00 0.48
CEA 17,022 Target Disease Neck Pain 5,675 7 0.00 -1.00 0.00 0.56
CEA 17,022 Target Disease Fibrocystic Breast Disease 173 3 0.00 -0.99 0.02 0.61
CEA 17,022 Target Disease Glomerulonephritis 23,459 7 0.00 -1.00 0.00 0.52
CEA 17,022 Target Disease Aspergillosis 9,759 2 0.00 -1.00 0.00 0.51
CEA 17,022 Target Disease Smallpox 6,258 3 0.00 -1.00 0.00 0.53
CEA 17,022 Target Disease Multiple Myeloma 24,594 6 0.00 -1.00 0.00 0.51
CEA 17,022 Target Disease Lung Carcinoma 13,423 113 0.01 -0.99 0.01 0.64
CEA 17,022 Target Disease Gastroesophageal Reflux Disease 7,437 1 0.00 -1.00 0.00 0.49
CEA 17,022 Target Disease Eating Disorders 9,000 5 0.00 -1.00 0.00 0.53
CEA 17,022 Target Disease Osteoporosis 46,215 11 0.00 -1.00 0.00 0.51
CEA 17,022 Target Disease Gynecomastia 2,594 1 0.00 -1.00 0.00 0.52
CEA 17,022 Target Disease Basal Cell Carcinoma 7,953 19 0.00 -1.00 0.00 0.58
CEA 17,022 Target Disease Renal Failure 73,993 58 0.00 -1.00 0.00 0.55
CEA 17,022 Target Disease Gallstones 8,280 6 0.00 -1.00 0.00 0.54
CEA 17,022 Target Disease Influenza 67,933 11 0.00 -1.00 0.00 0.50
CEA 17,022 Target Disease Ventricular Dysfunction 12,856 1 0.00 -1.00 0.00 0.48
CEA 17,022 Target Disease Sedation 27,984 23 0.00 -1.00 0.00 0.55
CEA 17,022 Target Disease Coma 24,208 11 0.00 -1.00 0.00 0.53
CEA 17,022 Target Disease Shock 134,031 57 0.00 -1.00 0.00 0.53
CEA 17,022 Target Disease Cerebral Edema 3,889 4 0.00 -1.00 0.00 0.55
CEA 17,022 Target Disease Pneumonia 81,521 47 0.00 -1.00 0.00 0.54
Mu Opioid Receptor 4,576 Target Disease Inflammation 252,734 121 0.00 -0.99 0.03 0.57
Mu Opioid Receptor 4,576 Target Disease Contraception 21,402 1 0.00 -1.00 0.00 0.50
Angiotensin Converting Enzyme 31,674 Target Disease Ankylosing Spondylitis 9,665 6 0.00 -1.00 0.00 0.52
Doxazosin 1,316 Drug Disease Diarrhea 51,986 1 0.00 -1.00 0.00 0.51